Adaptive Biotechnologies logo

Adaptive Biotechnologies

Seattle

Adaptive Biotechnologies develops technologies based on the adaptive immune system for disease diagnosis and treatment. It offers products such as T cell-based tests for early detection of diseases.

Facts

HQ
Seattle
Sectors
Biotechnology, Diagnostics, Healthcare
Type
Corporation Seattle business license
Registered name
Adaptive Biotechnologies Corporation Seattle business license
Stage
Public

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Adaptive Biotechnologies

See all 59

Harell Data Raises $15M to Reward Data Generators and Speed AI Drug Discovery, Founder Harlan Robins Launches New Cloud Service

Harell Data, founded by Harlan Robins, raised $15 million to build a cloud platform that better rewards data generators and accelerates AI-driven drug discovery by hosting proprietary, well-curated datasets and secure GPU compute. The service partners with CoreWeave and initial data contributors like A-Alpha Bio to provide datasets for model builders while creating revenue-sharing incentives for those who produce the data.

People

  • Chad Robins Executive, Chief Executive Officer
  • Harlan Robins Executive, Chief Scientific Officer
  • Mark Adams Executive, Chief Operating Officer

Questions about Adaptive Biotechnologies

What is Adaptive Biotechnologies?

Seattle

Who are the people behind Adaptive Biotechnologies?

Seattle Flow lists Chad Robins (Executive, Chief Executive Officer), Harlan Robins (Executive, Chief Scientific Officer) and Mark Adams (Executive, Chief Operating Officer) at Adaptive Biotechnologies.

Where is Adaptive Biotechnologies based?

Adaptive Biotechnologies is headquartered in Seattle.

When was Adaptive Biotechnologies founded?

Adaptive Biotechnologies was founded in 2009.